The invention covers a novel type of fibroblast growth factor called FGF-CX, which is useful for differentiation and expansion of various stem cells. The patent has 2 independent claims: 1 for the composition of matter itself, and the second for the composition of matter together with a pharmaceutically applicable carrier.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.